EPS
Earnings per share, a key profitability metric.
Latest EPS: $2.14 (2026Q1); -52.9% YoY; +3.6% CAGR since 2011Q1 (15y).
Chart and table show the latest 24 of 61 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly EPS Data
Chart and table show the latest 24 of 61 quarters.
| Period | Value |
|---|---|
| 2020Q2 | $1.36 |
| 2020Q3 | $1.33 |
| 2020Q4 | $0.65 |
| 2021Q1 | $2.32 |
| 2021Q2 | $2.35 |
| 2021Q3 | $1.37 |
| 2021Q4 | $1.77 |
| 2022Q1 | $1.93 |
| 2022Q2 | $1.80 |
| 2022Q3 | $1.68 |
| 2022Q4 | $1.32 |
| 2023Q1 | -$0.03 |
| 2023Q2 | $1.96 |
| 2023Q3 | $10.21 |
| 2023Q4 | $1.58 |
| 2024Q1 | $1.34 |
| 2024Q2 | $1.93 |
| 2024Q3 | $1.11 |
| 2024Q4 | $1.41 |
| 2025Q1 | $4.54 |
| 2025Q2 | $2.29 |
| 2025Q3 | $2.12 |
| 2025Q4 | $2.10 |
| 2026Q1 | $2.14 |
Healthcare Comparison
1 / 3
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 8